Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
出版年份 2020 全文链接
标题
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
作者
关键词
-
出版物
CA-A CANCER JOURNAL FOR CLINICIANS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-07-30
DOI
10.3322/caac.21628
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cost-effectiveness studies of HPV self-sampling: A systematic review
- (2020) Colin Malone et al. PREVENTIVE MEDICINE
- Diagnosis and Management of Adenocarcinoma in Situ
- (2020) Deanna Teoh et al. OBSTETRICS AND GYNECOLOGY
- Geographic and sociodemographic differences in cervical cancer screening modalities
- (2020) Ann Goding Sauer et al. PREVENTIVE MEDICINE
- Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening
- (2019) Kathy L. MacLaughlin et al. JOURNAL OF WOMENS HEALTH
- Absolute risks of cervical precancer among women who fulfil exiting guidelines based on HPV and cytology cotesting
- (2019) Rebecca Landy et al. INTERNATIONAL JOURNAL OF CANCER
- HPV infections and cytologic abnormalities in vaccinated women 21–34 years of age: Results from the baseline phase of the Onclarity trial
- (2019) Thomas C. Wright et al. GYNECOLOGIC ONCOLOGY
- Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014
- (2019) Nancy M. McClung et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Bethesda 2014 Implementation and Human Papillomavirus Primary Screening: Practices of Laboratories Participating in the College of American Pathologists PAP Education Program
- (2019) Diane Davis Davey et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England
- (2019) Irenjeet Bains et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
- (2019) Tim Palmer et al. BMJ-British Medical Journal
- Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016
- (2019) Nancy M. McClung et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States
- (2019) Farhad Islami et al. PREVENTIVE MEDICINE
- Rural–Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010–2014
- (2019) Lulu Yu et al. Preventing Chronic Disease
- Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology
- (2019) Thomas C. Wright et al. GYNECOLOGIC ONCOLOGY
- Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey
- (2019) Nancy M. McClung et al. JOURNAL OF ADOLESCENT HEALTH
- Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program
- (2019) C Sarai Racey et al. JOURNAL OF INFECTIOUS DISEASES
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018
- (2019) Tanja Y. Walker et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer
- (2018) Gui Liu et al. AIDS
- Cervical Cancer Screening Intervals Preferred by U.S. Women
- (2018) Crystale Purvis Cooper et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- The natural history of human papillomavirus infection
- (2018) Silvia de Sanjosé et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society
- (2018) Andrew M. D. Wolf et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system
- (2018) Rachel L. Winer et al. Contemporary Clinical Trials
- Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines
- (2018) Kine Pedersen et al. EUROPEAN JOURNAL OF CANCER
- The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
- (2018) Mark H. Stoler et al. GYNECOLOGIC ONCOLOGY
- Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months
- (2018) Gina Suzanne Ogilvie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HPV prevalence and HPV-related dysplasia in elderly women
- (2018) Ruth S. Hermansson et al. PLoS One
- How confident can we be in the current guidelines for exiting cervical screening?
- (2018) Patti E. Gravitt et al. PREVENTIVE MEDICINE
- Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting
- (2018) Katharine A. Rendle et al. PREVENTIVE MEDICINE
- Patterns and Trends in Cancer Screening in the United States
- (2018) Ingrid J. Hall et al. Preventing Chronic Disease
- Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis
- (2018) Christine Bekos et al. Scientific Reports
- Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
- (2018) Karen Canfell et al. BMJ Open
- Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis
- (2018) Karoliina Tainio et al. BMJ-British Medical Journal
- Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis
- (2018) Karoliina Tainio et al. BMJ-British Medical Journal
- Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population
- (2018) Thomas C Wright et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015
- (2018) Julia Warner Gargano et al. CLINICAL INFECTIOUS DISEASES
- Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing
- (2018) Joy Melnikow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Screening for Cervical Cancer in Primary Care
- (2018) Jane J. Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Screening for Cervical Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2017
- (2018) Tanja Y. Walker et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
- (2018) Alejandra Castañon et al. JOURNAL OF MEDICAL SCREENING
- Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results
- (2018) Philip E Castle et al. JNCI-Journal of the National Cancer Institute
- Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated women: a modelling study
- (2018) Talía Malagón et al. LANCET ONCOLOGY
- Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results
- (2018) Philip E. Castle et al. PREVENTIVE MEDICINE
- Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France
- (2017) Géric Maura et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Why does cervical cancer occur in a state-of-the-art screening program?
- (2017) Philip E. Castle et al. GYNECOLOGIC ONCOLOGY
- Harms of cervical cancer screening in the United States and the Netherlands
- (2017) Dik Habbema et al. INTERNATIONAL JOURNAL OF CANCER
- Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
- (2017) Sara E Oliver et al. JOURNAL OF INFECTIOUS DISEASES
- Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States
- (2017) Wonsuk Yoo et al. PLoS One
- Primary HPV testing recommendations of US providers, 2015
- (2017) Crystale Purvis Cooper et al. PREVENTIVE MEDICINE
- Understanding women's hesitancy to undergo less frequent cervical cancer screening
- (2017) Mary A. Gerend et al. PREVENTIVE MEDICINE
- Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm
- (2017) Joseph E. Tota et al. PREVENTIVE MEDICINE
- National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey
- (2017) Meg Watson et al. PREVENTIVE MEDICINE
- Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
- (2017) Jiangrong Wang et al. PLOS MEDICINE
- Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
- (2017) Karen Canfell et al. PLOS MEDICINE
- Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013
- (2017) Judith van der Horst et al. Cancer Medicine
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016
- (2017) Tanja Y. Walker et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era
- (2017) Vicki B. Benard et al. JAMA Oncology
- Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey
- (2016) Chengquan Zhao et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Case-control study of cervical cancer and gynecologic screening: A SEER-Medicare analysis
- (2016) Karin A. Rosenblatt et al. GYNECOLOGIC ONCOLOGY
- Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
- (2016) Alejandra Castanon et al. INTERNATIONAL JOURNAL OF CANCER
- Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
- (2016) Kate T. Simms et al. INTERNATIONAL JOURNAL OF CANCER
- Regression and Progression Predictors of CIN2 in Women Younger Than 25 Years
- (2016) Diede L. Loopik et al. Journal of Lower Genital Tract Disease
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Practice Bulletin No. 168 Summary
- (2016) OBSTETRICS AND GYNECOLOGY
- Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
- (2016) Steffie K. Naber et al. PLoS One
- Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
- (2016) Maria Kyrgiou et al. BMJ-British Medical Journal
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
- (2016) Pablo Alonso-Coello et al. BMJ-British Medical Journal
- Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
- (2016) Maria Kyrgiou et al. BMJ-British Medical Journal
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
- (2016) Pablo Alonso-Coello et al. BMJ-British Medical Journal
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Carcinogenic human papillomavirus infection
- (2016) Mark Schiffman et al. Nature Reviews Disease Primers
- Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians
- (2015) George F. Sawaya et al. ANNALS OF INTERNAL MEDICINE
- An Assessment of Gynecological Cytology Screening Practices Among Health Care Providers Nationwide
- (2015) May Darwish-Yassine et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Human Papillomavirus Testing and Reporting Rates in 2012: Results of a College of American Pathologists National Survey
- (2015) Chengquan Zhao et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
- (2015) Warner K. Huh et al. GYNECOLOGIC ONCOLOGY
- Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
- (2015) Thomas C. Wright et al. GYNECOLOGIC ONCOLOGY
- Breast Cancer Screening for Women at Average Risk
- (2015) Kevin C. Oeffinger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cervical Screening and Cervical Cancer Death Among Older Women: A Population-Based, Case-Control Study
- (2014) A. S. Rustagi et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Screening Pelvic Examinations in Asymptomatic, Average-Risk Adult Women: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians
- (2014) Hanna E. Bloomfield et al. ANNALS OF INTERNAL MEDICINE
- Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
- (2014) R Landy et al. BRITISH JOURNAL OF CANCER
- Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America
- (2014) H. Masur et al. CLINICAL INFECTIOUS DISEASES
- Role of cervical screening in older women
- (2014) Laurie Elit MATURITAS
- Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
- (2014) Alejandra Castañón et al. PLOS MEDICINE
- Counterpoint: Cervical Cancer Screening Guidelines--Approaching the Golden Age
- (2013) S. D. Isidean et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Challenges in Cervical Cancer Prevention
- (2013) Rebecca B. Perkins et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the U.S. Preventive Services Task Force
- (2013) Kimberly K. Vesco et al. ANNALS OF INTERNAL MEDICINE
- Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- A cross sectional study of HPV type prevalence according to age and cytology
- (2013) Elena Argyri et al. BMC INFECTIOUS DISEASES
- Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years
- (2013) A Castanon et al. BRITISH JOURNAL OF CANCER
- Efficacy of screening in preventing cervical cancer among older women
- (2013) Aruna Kamineni et al. CANCER CAUSES & CONTROL
- No Evidence for Synergy Between Human Papillomavirus Genotypes for the Risk of High-Grade Squamous Intraepithelial Lesions in a Large Population-Based Study
- (2013) Nicolas Wentzensen et al. JOURNAL OF INFECTIOUS DISEASES
- Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years
- (2013) Hormuzd A. Katki et al. Journal of Lower Genital Tract Disease
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- Follow-up Outcomes of a Large Cohort of Low-Risk Women With Negative Imaged Liquid-Based Cytology and Negative HPV Test Results
- (2012) Chengquan Zhao et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Association of Insurance Status and Age With Cervical Cancer Stage at Diagnosis: National Cancer Database, 2000–2007
- (2012) Stacey A. Fedewa et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
- (2012) Debbie Saslow et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Age-Specific Effectiveness of the Finnish Cervical Cancer Screening Programme
- (2012) S. Lonnberg et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Contributions of Recent and Past Sexual Partnerships on Incident Human Papillomavirus Detection: Acquisition and Reactivation in Older Women
- (2012) A. F. Rositch et al. CANCER RESEARCH
- Screening history preceding a diagnosis of cervical cancer in women age 65 and older
- (2012) Helen Dinkelspiel et al. GYNECOLOGIC ONCOLOGY
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland
- (2012) M. K. Leinonen et al. BMJ-British Medical Journal
- Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis
- (2011) Beibei Lu et al. BMC INFECTIOUS DISEASES
- New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines
- (2011) Otis Brawley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Invasive Cervical Cancer and Screening
- (2011) Akila Subramaniam et al. Journal of Lower Genital Tract Disease
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
- (2011) Hormuzd A Katki et al. LANCET ONCOLOGY
- A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)
- (2010) Gina S Ogilvie et al. BMC CANCER
- Cancer risk in DES daughters
- (2010) Janneke Verloop et al. CANCER CAUSES & CONTROL
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
- (2010) Guglielmo Ronco et al. LANCET ONCOLOGY
- Practice Improvement in Cervical Screening and Management (PICSM)
- (2009) Anna-Barbara Moscicki et al. Journal of Lower Genital Tract Disease
- HPV Screening for Cervical Cancer in Rural India
- (2009) Rengaswamy Sankaranarayanan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
- (2008) Chris J.L.M. Meijer et al. INTERNATIONAL JOURNAL OF CANCER
- Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden
- (2008) B. Andrae et al. JNCI-Journal of the National Cancer Institute
- The psychosocial impact of human papillomavirus testing in primary cervical screeninga study within a randomized trial
- (2007) H.C. KITCHENER et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started